Jakob S. Pallesen

A Comparative Assessment Study of Known Small-Molecule Keap1-Nrf2 Protein-Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity.

Alejandro Aguayo-Orozco, Dilip Narayanan, A. Bach, 2019, Journal of medicinal chemistry.

Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery.

G. Popowicz, M. Sattler, M. Gajhede, 2022, Journal of medicinal chemistry.

Deconstructing Noncovalent Kelch-like ECH-Associated Protein 1 (Keap1) Inhibitors into Fragments to Reconstruct New Potent Compounds.

G. Popowicz, M. Sattler, M. Gajhede, 2021, Journal of medicinal chemistry.

Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases.

A. Bach, Kim T Tran, Anders Bach, 2018, Journal of medicinal chemistry.

N1-Substituted Quinoxaline-2,3-diones as Kainate Receptor Antagonists: X-ray Crystallography, Structure-Affinity Relationships, and in Vitro Pharmacology.

J. Kastrup, D. Pickering, K. Frydenvang, 2019, ACS chemical neuroscience.

Designing Selective Drug-like Molecular Glues for the Glucocorticoid Receptor/14-3-3 Protein–Protein Interaction

C. Ottmann, Andrew J. Wilson, A. Gunnarsson, 2022, Journal of medicinal chemistry.